My Pick for the Rest of 2023 Can Help AI Meet Its Potential

This cutting-edge technology company is poised to propel artificial intelligence to the next level.

This Biotech Stock Pick Is Just Starting to Make Beautiful Music

Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.

Mirum Pharmaceuticals Merits a Healthy Endorsement Based on Its Charts

The shares of the biopharmaceutical company appear to have broken out to the upside.

I Wouldn't Plant Money in Deere Despite an Analyst's Big Thumbs Up

The charts of the farm equipment giant suggest its stock could head downward significantly in the weeks ahead.

Fed's Message, Markets, Retail Sales, Triple Witching Friday

The FOMC will have to altar market expectations for the November 1st decision in order to restore flexibility/optionality in decision making.

The Goldilocks Economic Narrative Returns, But the Bears Aren't Going to Give Up

The battle continues, and the best way to navigate it is to stay focused on price action.

Sorting Through the Strange Sentiment Statistics

Let's pop the hood and check the market's mood -- and that low VIX reading.

Bulls Buy on Lower Odds of Rate Hike, but Is It a Trap?

Let's digest the economic news of the day, why we rallied, and what perils could be ahead.

My Pick for the Rest of 2023: GM, as It Readies to 'Cruise' Ahead

GM shares are languishing amid UAW strike fears, but in the background, Cruise is rolling out its robotaxi ride-hail service in city after city, and shows great promise ahead.

Will Occidental Petroleum Finally Make an Upside Breakout?

Let's see how convincing the charts look.